APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mucopolysaccharidosis II

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mucopolysaccharidosis II Market Analysis and Forecast 2026-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchMucopolysaccharidosis II Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Mucopolysaccharidosis II Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Mucopolysaccharidosis II Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mucopolysaccharidosis II Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mucopolysaccharidosis II Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Mucopolysaccharidosis II market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Mucopolysaccharidosis II is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mucopolysaccharidosis II is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mucopolysaccharidosis II is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mucopolysaccharidosis II is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Mucopolysaccharidosis II include Takeda, Sangamo BioSciences, Inc., RegenxBio Inc., Laboratorios Del Dr. Esteve S.A., JCR Pharmaceuticals Co., Ltd., Inventiva, Green Cross Corporation, Bioasis Technologies Inc. and ArmaGen Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Mucopolysaccharidosis II, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mucopolysaccharidosis II, also provides the sales of main regions and countries. Of the upcoming market potential for Mucopolysaccharidosis II, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mucopolysaccharidosis II sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mucopolysaccharidosis II market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Mucopolysaccharidosis II sales, projected growth trends, production technology, application and end-user industry.

Mucopolysaccharidosis II Segment by Company

Takeda

Sangamo BioSciences, Inc.

RegenxBio Inc.

Laboratorios Del Dr. Esteve S.A.

JCR Pharmaceuticals Co., Ltd.

Inventiva

Green Cross Corporation

Bioasis Technologies Inc.

ArmaGen Inc.

AngioChem Inc.

Alexion Pharmaceuticals, Inc.

Mucopolysaccharidosis II Segment by Type

AGT-182

DUOC-01

EGT-301

JR-032

JR-141

Others

Mucopolysaccharidosis II Segment by Application

Clinic

Hospital

Research Center

Others

Mucopolysaccharidosis II Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mucopolysaccharidosis II market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mucopolysaccharidosis II and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mucopolysaccharidosis II.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Mucopolysaccharidosis II in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Mucopolysaccharidosis II manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mucopolysaccharidosis II sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mucopolysaccharidosis II Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. AGT-182 Major Manufacturers Table 3. DUOC-01 Major Manufacturers Table 4. EGT-301 Major Manufacturers Table 5. JR-032 Major Manufacturers Table 6. JR-141 Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Mucopolysaccharidosis II Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Clinic Major Manufacturers Table 10. Hospital Major Manufacturers Table 11. Research Center Major Manufacturers Table 12. Others Major Manufacturers Table 13. Mucopolysaccharidosis II Industry Trends Table 14. Mucopolysaccharidosis II Industry Drivers Table 15. Mucopolysaccharidosis II Industry Opportunities and Challenges Table 16. Mucopolysaccharidosis II Industry Restraints Table 17. Global Mucopolysaccharidosis II Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Mucopolysaccharidosis II Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Mucopolysaccharidosis II Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Mucopolysaccharidosis II Revenue Market Share by Region (2021-2026) Table 21. Global Mucopolysaccharidosis II Revenue Market Share by Region (2027-2032) Table 22. Global Mucopolysaccharidosis II Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Mucopolysaccharidosis II Sales by Region (2021-2026) & (W Units) Table 24. Global Mucopolysaccharidosis II Sales by Region (2027-2032) & (W Units) Table 25. Global Mucopolysaccharidosis II Sales Market Share by Region (2021-2026) Table 26. Global Mucopolysaccharidosis II Sales Market Share by Region (2027-2032) Table 27. Global Mucopolysaccharidosis II Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Mucopolysaccharidosis II Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Mucopolysaccharidosis II Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2021-2026) Table 31. Global Mucopolysaccharidosis II Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Mucopolysaccharidosis II Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Mucopolysaccharidosis II Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Mucopolysaccharidosis II Manufacturers, Product Type & Application Table 35. Global Mucopolysaccharidosis II Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Mucopolysaccharidosis II by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Mucopolysaccharidosis II Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Mucopolysaccharidosis II Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Mucopolysaccharidosis II Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Mucopolysaccharidosis II Revenue Market Share by Type (2021-2026) Table 42. Global Mucopolysaccharidosis II Revenue Market Share by Type (2027-2032) Table 43. Global Mucopolysaccharidosis II Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 45. Global Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 46. Global Mucopolysaccharidosis II Sales Market Share by Type (2021-2026) Table 47. Global Mucopolysaccharidosis II Sales Market Share by Type (2027-2032) Table 48. Global Mucopolysaccharidosis II Price by Type (2021-2026) & (US$/Unit) Table 49. Global Mucopolysaccharidosis II Price by Type (2027-2032) & (US$/Unit) Table 50. Global Mucopolysaccharidosis II Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Mucopolysaccharidosis II Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Mucopolysaccharidosis II Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Mucopolysaccharidosis II Revenue Market Share by Application (2021-2026) Table 54. Global Mucopolysaccharidosis II Revenue Market Share by Application (2027-2032) Table 55. Global Mucopolysaccharidosis II Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 57. Global Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 58. Global Mucopolysaccharidosis II Sales Market Share by Application (2021-2026) Table 59. Global Mucopolysaccharidosis II Sales Market Share by Application (2027-2032) Table 60. Global Mucopolysaccharidosis II Price by Application (2021-2026) & (US$/Unit) Table 61. Global Mucopolysaccharidosis II Price by Application (2027-2032) & (US$/Unit) Table 62. Takeda Company Information Table 63. Takeda Business Overview Table 64. Takeda Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Takeda Mucopolysaccharidosis II Product Portfolio Table 66. Takeda Recent Development Table 67. Sangamo BioSciences, Inc. Company Information Table 68. Sangamo BioSciences, Inc. Business Overview Table 69. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio Table 71. Sangamo BioSciences, Inc. Recent Development Table 72. RegenxBio Inc. Company Information Table 73. RegenxBio Inc. Business Overview Table 74. RegenxBio Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio Table 76. RegenxBio Inc. Recent Development Table 77. Laboratorios Del Dr. Esteve S.A. Company Information Table 78. Laboratorios Del Dr. Esteve S.A. Business Overview Table 79. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio Table 81. Laboratorios Del Dr. Esteve S.A. Recent Development Table 82. JCR Pharmaceuticals Co., Ltd. Company Information Table 83. JCR Pharmaceuticals Co., Ltd. Business Overview Table 84. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio Table 86. JCR Pharmaceuticals Co., Ltd. Recent Development Table 87. Inventiva Company Information Table 88. Inventiva Business Overview Table 89. Inventiva Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Inventiva Mucopolysaccharidosis II Product Portfolio Table 91. Inventiva Recent Development Table 92. Green Cross Corporation Company Information Table 93. Green Cross Corporation Business Overview Table 94. Green Cross Corporation Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Green Cross Corporation Mucopolysaccharidosis II Product Portfolio Table 96. Green Cross Corporation Recent Development Table 97. Bioasis Technologies Inc. Company Information Table 98. Bioasis Technologies Inc. Business Overview Table 99. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio Table 101. Bioasis Technologies Inc. Recent Development Table 102. ArmaGen Inc. Company Information Table 103. ArmaGen Inc. Business Overview Table 104. ArmaGen Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio Table 106. ArmaGen Inc. Recent Development Table 107. AngioChem Inc. Company Information Table 108. AngioChem Inc. Business Overview Table 109. AngioChem Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. AngioChem Inc. Mucopolysaccharidosis II Product Portfolio Table 111. AngioChem Inc. Recent Development Table 112. Alexion Pharmaceuticals, Inc. Company Information Table 113. Alexion Pharmaceuticals, Inc. Business Overview Table 114. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio Table 116. Alexion Pharmaceuticals, Inc. Recent Development Table 117. North America Mucopolysaccharidosis II Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Mucopolysaccharidosis II Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 120. North America Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 121. North America Mucopolysaccharidosis II Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Mucopolysaccharidosis II Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Mucopolysaccharidosis II Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Mucopolysaccharidosis II Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 126. North America Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 127. North America Mucopolysaccharidosis II Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Mucopolysaccharidosis II Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Mucopolysaccharidosis II Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Mucopolysaccharidosis II Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 133. North America Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 134. North America Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 135. North America Mucopolysaccharidosis II Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Mucopolysaccharidosis II Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 138. Canada Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 139. Mexico Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 140. Europe Mucopolysaccharidosis II Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Mucopolysaccharidosis II Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 143. Europe Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 144. Europe Mucopolysaccharidosis II Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Europe Mucopolysaccharidosis II Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Europe Mucopolysaccharidosis II Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Mucopolysaccharidosis II Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 149. Europe Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 150. Europe Mucopolysaccharidosis II Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Europe Mucopolysaccharidosis II Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Europe Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Mucopolysaccharidosis II Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Mucopolysaccharidosis II Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 156. Europe Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 157. Europe Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 158. Europe Mucopolysaccharidosis II Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Europe Mucopolysaccharidosis II Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Germany Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 161. France Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 162. U.K. Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 163. Italy Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 164. Russia Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 165. Spain Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 168. Sweden Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 169. Poland Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 170. China Mucopolysaccharidosis II Revenue by Type (2021-2026) & (US$ Million) Table 171. China Mucopolysaccharidosis II Revenue by Type (2027-2032) & (US$ Million) Table 172. China Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 173. China Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 174. China Mucopolysaccharidosis II Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Mucopolysaccharidosis II Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Mucopolysaccharidosis II Revenue by Application (2021-2026) & (US$ Million) Table 177. China Mucopolysaccharidosis II Revenue by Application (2027-2032) & (US$ Million) Table 178. China Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 179. China Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 180. China Mucopolysaccharidosis II Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Mucopolysaccharidosis II Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Mucopolysaccharidosis II Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Mucopolysaccharidosis II Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 185. Asia Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 186. Asia Mucopolysaccharidosis II Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Mucopolysaccharidosis II Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Mucopolysaccharidosis II Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Mucopolysaccharidosis II Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 191. Asia Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 192. Asia Mucopolysaccharidosis II Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Mucopolysaccharidosis II Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Mucopolysaccharidosis II Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Mucopolysaccharidosis II Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 198. Asia Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 199. Asia Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 200. Asia Mucopolysaccharidosis II Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Mucopolysaccharidosis II Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 203. South Korea Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 204. India Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 205. Australia Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Mucopolysaccharidosis II Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Mucopolysaccharidosis II Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Mucopolysaccharidosis II Sales by Type (2021-2026) & (W Units) Table 211. SAMEA Mucopolysaccharidosis II Sales by Type (2027-2032) & (W Units) Table 212. SAMEA Mucopolysaccharidosis II Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Mucopolysaccharidosis II Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Mucopolysaccharidosis II Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Mucopolysaccharidosis II Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Mucopolysaccharidosis II Sales by Application (2021-2026) & (W Units) Table 217. SAMEA Mucopolysaccharidosis II Sales by Application (2027-2032) & (W Units) Table 218. SAMEA Mucopolysaccharidosis II Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Mucopolysaccharidosis II Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Mucopolysaccharidosis II Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Mucopolysaccharidosis II Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 224. SAMEA Mucopolysaccharidosis II Sales by Country (2021-2026) & (W Units) Table 225. SAMEA Mucopolysaccharidosis II Sales by Country (2027-2032) & (W Units) Table 226. SAMEA Mucopolysaccharidosis II Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Mucopolysaccharidosis II Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 229. Argentina Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 230. Chile Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 231. Colombia Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 232. Peru Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 234. Israel Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 235. UAE Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 236. Turkey Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 237. Iran Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 238. Egypt Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Mucopolysaccharidosis II Distributors List Table 242. Mucopolysaccharidosis II Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Mucopolysaccharidosis II Image Figure 2. Global Mucopolysaccharidosis II Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mucopolysaccharidosis II Market Size Share 2021 VS 2025 VS 2032 Figure 4. AGT-182 Image Figure 5. DUOC-01 Image Figure 6. EGT-301 Image Figure 7. JR-032 Image Figure 8. JR-141 Image Figure 9. Others Image Figure 10. Global Mucopolysaccharidosis II Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Mucopolysaccharidosis II Market Size Share 2021 VS 2025 VS 2032 Figure 12. Clinic Image Figure 13. Hospital Image Figure 14. Research Center Image Figure 15. Others Image Figure 16. Global Mucopolysaccharidosis II Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Mucopolysaccharidosis II Revenue (2021-2032) & (US$ Million) Figure 18. Global Mucopolysaccharidosis II Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Mucopolysaccharidosis II Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Mucopolysaccharidosis II Revenue Market Share by Region (2021-2032) Figure 21. Global Mucopolysaccharidosis II Sales (2021-2032) & (W Units) Figure 22. Global Mucopolysaccharidosis II Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Mucopolysaccharidosis II Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Mucopolysaccharidosis II Sales YoY (2021-2032) & (W Units) Figure 25. Europe Mucopolysaccharidosis II Sales YoY (2021-2032) & (W Units) Figure 26. China Mucopolysaccharidosis II Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Mucopolysaccharidosis II Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Mucopolysaccharidosis II Sales YoY (2021-2032) & (W Units) Figure 29. Global Mucopolysaccharidosis II Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Mucopolysaccharidosis II Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Mucopolysaccharidosis II Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Mucopolysaccharidosis II Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Mucopolysaccharidosis II Revenue Market Share by Type (2021-2032) Figure 35. Global Mucopolysaccharidosis II Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Mucopolysaccharidosis II Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Mucopolysaccharidosis II Sales Market Share by Type (2021-2032) Figure 38. Global Mucopolysaccharidosis II Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Mucopolysaccharidosis II Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Mucopolysaccharidosis II Revenue Market Share by Application (2021-2032) Figure 41. Global Mucopolysaccharidosis II Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Mucopolysaccharidosis II Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Mucopolysaccharidosis II Sales Market Share by Application (2021-2032) Figure 44. North America Mucopolysaccharidosis II Revenue Share by Type (2021-2032) Figure 45. North America Mucopolysaccharidosis II Sales Share by Type (2021-2032) Figure 46. North America Mucopolysaccharidosis II Revenue Share by Application (2021-2032) Figure 47. North America Mucopolysaccharidosis II Sales Share by Application (2021-2032) Figure 48. North America Mucopolysaccharidosis II Revenue Share by Country (2021-2032) Figure 49. North America Mucopolysaccharidosis II Sales Share by Country (2021-2032) Figure 50. Europe Mucopolysaccharidosis II Revenue Share by Type (2021-2032) Figure 51. Europe Mucopolysaccharidosis II Sales Share by Type (2021-2032) Figure 52. Europe Mucopolysaccharidosis II Revenue Share by Application (2021-2032) Figure 53. Europe Mucopolysaccharidosis II Sales Share by Application (2021-2032) Figure 54. Europe Mucopolysaccharidosis II Revenue Share by Country (2021-2032) Figure 55. Europe Mucopolysaccharidosis II Sales Share by Country (2021-2032) Figure 56. China Mucopolysaccharidosis II Revenue Share by Type (2021-2032) Figure 57. China Mucopolysaccharidosis II Sales Share by Type (2021-2032) Figure 58. China Mucopolysaccharidosis II Revenue Share by Application (2021-2032) Figure 59. China Mucopolysaccharidosis II Sales Share by Application (2021-2032) Figure 60. Asia Mucopolysaccharidosis II Revenue Share by Type (2021-2032) Figure 61. Asia Mucopolysaccharidosis II Sales Share by Type (2021-2032) Figure 62. Asia Mucopolysaccharidosis II Revenue Share by Application (2021-2032) Figure 63. Asia Mucopolysaccharidosis II Sales Share by Application (2021-2032) Figure 64. Asia Mucopolysaccharidosis II Revenue Share by Country (2021-2032) Figure 65. Asia Mucopolysaccharidosis II Sales Share by Country (2021-2032) Figure 66. SAMEA Mucopolysaccharidosis II Revenue Share by Type (2021-2032) Figure 67. SAMEA Mucopolysaccharidosis II Sales Share by Type (2021-2032) Figure 68. SAMEA Mucopolysaccharidosis II Revenue Share by Application (2021-2032) Figure 69. SAMEA Mucopolysaccharidosis II Sales Share by Application (2021-2032) Figure 70. SAMEA Mucopolysaccharidosis II Revenue Share by Country (2021-2032) Figure 71. SAMEA Mucopolysaccharidosis II Sales Share by Country (2021-2032) Figure 72. Mucopolysaccharidosis II Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Mucopolysaccharidosis II Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • AGT-182
  • DUOC-01
  • EGT-301
  • JR-032
  • JR-141
  • Others
Applications
  • Clinic
  • Hospital
  • Research Center
  • Others
Companies covered
  • Takeda
  • Sangamo BioSciences, Inc.
  • RegenxBio Inc.
  • Laboratorios Del Dr. Esteve S.A.
  • JCR Pharmaceuticals Co., Ltd.
  • Inventiva
  • Green Cross Corporation
  • Bioasis Technologies Inc.
  • ArmaGen Inc.
  • AngioChem Inc.
  • Alexion Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mucopolysaccharidosis II Market by Type
  3. 1.2.1 Global Mucopolysaccharidosis II Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 AGT-182
  5. 1.2.3 DUOC-01
  6. 1.2.4 EGT-301
  7. 1.2.5 JR-032
  8. 1.2.6 JR-141
  9. 1.2.7 Others
  10. 1.3 Mucopolysaccharidosis II Market by Application
  11. 1.3.1 Global Mucopolysaccharidosis II Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Clinic
  13. 1.3.3 Hospital
  14. 1.3.4 Research Center
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Mucopolysaccharidosis II Market Dynamics
  1. 2.1 Mucopolysaccharidosis II Industry Trends
  2. 2.2 Mucopolysaccharidosis II Industry Drivers
  3. 2.3 Mucopolysaccharidosis II Industry Opportunities and Challenges
  4. 2.4 Mucopolysaccharidosis II Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Mucopolysaccharidosis II Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Mucopolysaccharidosis II Revenue by Region
  3. 3.2.1 Global Mucopolysaccharidosis II Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mucopolysaccharidosis II Revenue by Region (2021-2026)
  5. 3.2.3 Global Mucopolysaccharidosis II Revenue by Region (2027-2032)
  6. 3.2.4 Global Mucopolysaccharidosis II Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Mucopolysaccharidosis II Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Mucopolysaccharidosis II Sales by Region
  9. 3.4.1 Global Mucopolysaccharidosis II Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Mucopolysaccharidosis II Sales by Region (2021-2026)
  11. 3.4.3 Global Mucopolysaccharidosis II Sales by Region (2027-2032)
  12. 3.4.4 Global Mucopolysaccharidosis II Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Mucopolysaccharidosis II Revenue by Manufacturers
  2. 4.1.1 Global Mucopolysaccharidosis II Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Mucopolysaccharidosis II Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Mucopolysaccharidosis II Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mucopolysaccharidosis II Sales by Manufacturers
  6. 4.2.1 Global Mucopolysaccharidosis II Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Mucopolysaccharidosis II Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Mucopolysaccharidosis II Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Mucopolysaccharidosis II Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Mucopolysaccharidosis II Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Mucopolysaccharidosis II Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Mucopolysaccharidosis II Manufacturers, Product Type & Application
  13. 4.7 Global Mucopolysaccharidosis II Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Mucopolysaccharidosis II Market CR5 and HHI
  16. 4.8.2 2025 Mucopolysaccharidosis II Tier 1, Tier 2, and Tier 3
5 Mucopolysaccharidosis II Market by Type
  1. 5.1 Global Mucopolysaccharidosis II Revenue by Type
  2. 5.1.1 Global Mucopolysaccharidosis II Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Mucopolysaccharidosis II Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Mucopolysaccharidosis II Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Mucopolysaccharidosis II Sales by Type
  6. 5.2.1 Global Mucopolysaccharidosis II Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mucopolysaccharidosis II Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Mucopolysaccharidosis II Sales Market Share by Type (2021-2032)
  9. 5.3 Global Mucopolysaccharidosis II Price by Type
6 Mucopolysaccharidosis II Market by Application
  1. 6.1 Global Mucopolysaccharidosis II Revenue by Application
  2. 6.1.1 Global Mucopolysaccharidosis II Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Mucopolysaccharidosis II Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Mucopolysaccharidosis II Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Mucopolysaccharidosis II Sales by Application
  6. 6.2.1 Global Mucopolysaccharidosis II Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Mucopolysaccharidosis II Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Mucopolysaccharidosis II Sales Market Share by Application (2021-2032)
  9. 6.3 Global Mucopolysaccharidosis II Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Mucopolysaccharidosis II Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Sangamo BioSciences, Inc.
  8. 7.2.1 Sangamo BioSciences, Inc. Company Information
  9. 7.2.2 Sangamo BioSciences, Inc. Business Overview
  10. 7.2.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product Portfolio
  12. 7.2.5 Sangamo BioSciences, Inc. Recent Developments
  13. 7.3 RegenxBio Inc.
  14. 7.3.1 RegenxBio Inc. Company Information
  15. 7.3.2 RegenxBio Inc. Business Overview
  16. 7.3.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 RegenxBio Inc. Mucopolysaccharidosis II Product Portfolio
  18. 7.3.5 RegenxBio Inc. Recent Developments
  19. 7.4 Laboratorios Del Dr. Esteve S.A.
  20. 7.4.1 Laboratorios Del Dr. Esteve S.A. Company Information
  21. 7.4.2 Laboratorios Del Dr. Esteve S.A. Business Overview
  22. 7.4.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product Portfolio
  24. 7.4.5 Laboratorios Del Dr. Esteve S.A. Recent Developments
  25. 7.5 JCR Pharmaceuticals Co., Ltd.
  26. 7.5.1 JCR Pharmaceuticals Co., Ltd. Company Information
  27. 7.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
  28. 7.5.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product Portfolio
  30. 7.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
  31. 7.6 Inventiva
  32. 7.6.1 Inventiva Company Information
  33. 7.6.2 Inventiva Business Overview
  34. 7.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Inventiva Mucopolysaccharidosis II Product Portfolio
  36. 7.6.5 Inventiva Recent Developments
  37. 7.7 Green Cross Corporation
  38. 7.7.1 Green Cross Corporation Company Information
  39. 7.7.2 Green Cross Corporation Business Overview
  40. 7.7.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Green Cross Corporation Mucopolysaccharidosis II Product Portfolio
  42. 7.7.5 Green Cross Corporation Recent Developments
  43. 7.8 Bioasis Technologies Inc.
  44. 7.8.1 Bioasis Technologies Inc. Company Information
  45. 7.8.2 Bioasis Technologies Inc. Business Overview
  46. 7.8.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Product Portfolio
  48. 7.8.5 Bioasis Technologies Inc. Recent Developments
  49. 7.9 ArmaGen Inc.
  50. 7.9.1 ArmaGen Inc. Company Information
  51. 7.9.2 ArmaGen Inc. Business Overview
  52. 7.9.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ArmaGen Inc. Mucopolysaccharidosis II Product Portfolio
  54. 7.9.5 ArmaGen Inc. Recent Developments
  55. 7.10 AngioChem Inc.
  56. 7.10.1 AngioChem Inc. Company Information
  57. 7.10.2 AngioChem Inc. Business Overview
  58. 7.10.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 AngioChem Inc. Mucopolysaccharidosis II Product Portfolio
  60. 7.10.5 AngioChem Inc. Recent Developments
  61. 7.11 Alexion Pharmaceuticals, Inc.
  62. 7.11.1 Alexion Pharmaceuticals, Inc. Company Information
  63. 7.11.2 Alexion Pharmaceuticals, Inc. Business Overview
  64. 7.11.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product Portfolio
  66. 7.11.5 Alexion Pharmaceuticals, Inc. Recent Developments
8 North America
  1. 8.1 North America Mucopolysaccharidosis II Market Size by Type
  2. 8.1.1 North America Mucopolysaccharidosis II Revenue by Type (2021-2032)
  3. 8.1.2 North America Mucopolysaccharidosis II Sales by Type (2021-2032)
  4. 8.1.3 North America Mucopolysaccharidosis II Price by Type (2021-2032)
  5. 8.2 North America Mucopolysaccharidosis II Market Size by Application
  6. 8.2.1 North America Mucopolysaccharidosis II Revenue by Application (2021-2032)
  7. 8.2.2 North America Mucopolysaccharidosis II Sales by Application (2021-2032)
  8. 8.2.3 North America Mucopolysaccharidosis II Price by Application (2021-2032)
  9. 8.3 North America Mucopolysaccharidosis II Market Size by Country
  10. 8.3.1 North America Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Mucopolysaccharidosis II Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Mucopolysaccharidosis II Market Size by Type
  2. 9.1.1 Europe Mucopolysaccharidosis II Revenue by Type (2021-2032)
  3. 9.1.2 Europe Mucopolysaccharidosis II Sales by Type (2021-2032)
  4. 9.1.3 Europe Mucopolysaccharidosis II Price by Type (2021-2032)
  5. 9.2 Europe Mucopolysaccharidosis II Market Size by Application
  6. 9.2.1 Europe Mucopolysaccharidosis II Revenue by Application (2021-2032)
  7. 9.2.2 Europe Mucopolysaccharidosis II Sales by Application (2021-2032)
  8. 9.2.3 Europe Mucopolysaccharidosis II Price by Application (2021-2032)
  9. 9.3 Europe Mucopolysaccharidosis II Market Size by Country
  10. 9.3.1 Europe Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Mucopolysaccharidosis II Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Mucopolysaccharidosis II Market Size by Type
  2. 10.1.1 China Mucopolysaccharidosis II Revenue by Type (2021-2032)
  3. 10.1.2 China Mucopolysaccharidosis II Sales by Type (2021-2032)
  4. 10.1.3 China Mucopolysaccharidosis II Price by Type (2021-2032)
  5. 10.2 China Mucopolysaccharidosis II Market Size by Application
  6. 10.2.1 China Mucopolysaccharidosis II Revenue by Application (2021-2032)
  7. 10.2.2 China Mucopolysaccharidosis II Sales by Application (2021-2032)
  8. 10.2.3 China Mucopolysaccharidosis II Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mucopolysaccharidosis II Market Size by Type
  2. 11.1.1 Asia Mucopolysaccharidosis II Revenue by Type (2021-2032)
  3. 11.1.2 Asia Mucopolysaccharidosis II Sales by Type (2021-2032)
  4. 11.1.3 Asia Mucopolysaccharidosis II Price by Type (2021-2032)
  5. 11.2 Asia Mucopolysaccharidosis II Market Size by Application
  6. 11.2.1 Asia Mucopolysaccharidosis II Revenue by Application (2021-2032)
  7. 11.2.2 Asia Mucopolysaccharidosis II Sales by Application (2021-2032)
  8. 11.2.3 Asia Mucopolysaccharidosis II Price by Application (2021-2032)
  9. 11.3 Asia Mucopolysaccharidosis II Market Size by Country
  10. 11.3.1 Asia Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Mucopolysaccharidosis II Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mucopolysaccharidosis II Market Size by Type
  2. 12.1.1 SAMEA Mucopolysaccharidosis II Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Mucopolysaccharidosis II Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Mucopolysaccharidosis II Price by Type (2021-2032)
  5. 12.2 SAMEA Mucopolysaccharidosis II Market Size by Application
  6. 12.2.1 SAMEA Mucopolysaccharidosis II Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Mucopolysaccharidosis II Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Mucopolysaccharidosis II Price by Application (2021-2032)
  9. 12.3 SAMEA Mucopolysaccharidosis II Market Size by Country
  10. 12.3.1 SAMEA Mucopolysaccharidosis II Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Mucopolysaccharidosis II Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Mucopolysaccharidosis II Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Mucopolysaccharidosis II Value Chain Analysis
  2. 13.1.1 Mucopolysaccharidosis II Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Mucopolysaccharidosis II Production Mode & Process
  6. 13.2 Mucopolysaccharidosis II Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Mucopolysaccharidosis II Distributors
  9. 13.2.3 Mucopolysaccharidosis II Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst